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ABSTRACT
Objective: This study aimed to compare the characteristics of four buccal films formulated with phthalylated cassava starch and their drug delivery 
potentials.
Methods: An alternative to conventional (oral) drug administration is to administer drugs in a buccal film; however, the required dosage must 
be dissolved in a film-forming polymer with suitable mechanical and mucoadhesive characteristics. Previous studies have produced excipients 
by physically and chemically modifying starch, such as by completely pregelatinization and phthalylation it in an aqueous medium under alkaline 
conditions (pH 8–10). This produced a pregelatinized cassava starch phthalate (PCSPh) powder with a high degree of substitution (0.0541±0.0019), 
thus giving it different physical, chemical, and functional characteristics than unphthalated PCS.
Results: PCSPh in 4.5% and 6% (w/w) concentrations was used as excipients for producing four formulations of buccal film. One film had the 
most suitable characteristics, with an ex vivo mucoadhesion time of 57.1±20.3 min, tensile strength of 0.84±0.02 N/mm2, and a more rapid drug 
release profile than two of the other film types produced. Our tests also revealed that the best film tended to not change physically when moistened 
(percentage moisture absorption was 139% and moisture loss was 65%).
Conclusion: Thus, we predict that PCSPh could be adequately formulated to provide mucoadhesive buccal films with an appropriate drug release profile.
Keywords: Buccal film, Film-forming polymer, Modification of starch, Mucoadhesive, Pregelatinized cassava starch phthalate.
INTRODUCTION
Although patients and clinicians prefer orally administered drugs, this 
type of delivery system has a number of disadvantages, including hepatic 
first-pass metabolism, gastric irritation, and enzymatic degradation 
within the gastrointestinal tract. The buccal route for delivering drugs 
has been advocated as an alternative to oral administration because 
venous blood reaches the heart directly through the internal jugular 
vein [1]. The principle of mucoadhesion offers a simple and practical 
approach to achieve increased mucoadhesive residence time for the 
dosage form and sustained drug release [2]. Moreover, transmucosal 
absorption of drugs into the circulation system provides a number of 
other advantages, such as rapid action, high permeability, and high 
blood flow. Furthermore, the buccal area is easily accessible for both 
applying and removing drug delivery devices [3].
Biopolymers (e.g., starches) are commonly used to make thermoplastic 
buccal films because they are biodegradable. Since utilization of starch 
in pharmaceutical dosage forms is sometimes limited by its solubility 
(unsoluble in cold-water) and mechanical properties (low flexibility 
and tensile strength), some modification (physical, chemical, and 
enzymatically) are required to improve the characteristic of starch [4]. 
Here, we chose pregelatinized cassava starch phthalate (PCSPh) 
(a starch derivative) as an excipient for three different buccal films. We 
then compared characteristics of these films with a film prepared with 
PCS. We used diltiazem hydrochloride (DH), a calcium channel blocker 
belonging to the benzothiazepine family, as our drug model because it 
is widely prescribed for hypertension and angina. Nevertheless, it has 
poor bioavailability (30–40%) and a short biological half-life (3–5 h) 
with an initial dose of 60–120 mg delivered twice daily [5]. We aimed 




Various combinations of the following materials were combined as 
formula for four different mucoadhesive buccal film tablets: diltiazem 
hydrochloride (Piramal, India), PCSPh (Universitas Indonesia, Indonesia), 
glycerol (Brataco, Indonesia), propylene glycol (Brataco, Indonesia), 
aspartame (Vitasweet, China), sodium hydroxide (Merck, Germany), 
potassium dihydrogen phosphate (Merck, Germany), goat buccal sections 
(Pasar Agung, Indonesia), and Aquadest (Brataco, Indonesia).
Preparing DH mucoadhesive buccal films
We used four different formulas to create mucoadhesive buccal film 
tablets (Table 1). The buccal film tablets were prepared using the 
solvent casting method with aquadest as the solvent for all films. 
Each film type was formulated by combining a dispersed polymer in 
aquadest with a solution of DH (an active pharmaceutical ingredient), 
aspartame, and a solution of plasticizer (containing propylenglycol 
and glycerol). Each solution was mixed with a magnetic stirrer until 
thoroughly homogenized. The mixture then was left to stand for several 
hours at room temperature to ensure the production of a bubble-free 
solution. The resulting solution was then poured in a Tupperware mold 
and dried in an oven at 50ºC until a flexible film formed. After drying, the 
film was carefully removed from the Tupperware mold. Equal dosages 
were created by cutting the film so that each film tablet contained 
25 mg diltiazem HCl. Each tablet was then packed in aluminum foil and 
stored in a glass desiccator at room temperature until tested [6].
Film morphology
Morphologies of the buccal films were observed on various surfaces 
(topside, bottom side, and cross-section) using a scanning electron 
microscope (SEM).
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Film weight and thickness
To evaluate film weight, five random samples of every film composition 
(four formulations) were weighed individually on a digital balance 
(Mettler Toledo AL204, USA) and then the  average weight for each type 
of film was calculated. The thickness of each film type was determined 
by measuring each type at five different locations (at center and four 
peripheral locations) using a micrometer screw gauge (Din: 863/11, 
England). Then, the mean of film thickness was calculated for each film 
type.
Surface pH
We used the method adopted by Bottenberg et al., to determine the 
surface pH of a tablet with a pH-meter [7]. The films were allowed 
to swell by keeping them in contact with 5 mL of distilled water 
(pH 6.5±0.1) for 2 h at room temperature. pH for swollen films was 
obtained by placing the glass electrode of the pH-meter (Eutech pH 510, 
Singapore) in contact with the microenvironment of the swollen film 
and allowing it to equilibrate for 1 min. The average pH of three 
measurements was reported.
Moisture content
The moisture content of each film (mean of triplicate readings) was 
determined and recorded using a moisture content analyzer (Adam 
AMB50, UK) at 105°C.
Folding endurance
Three random films of each formulation (type) were cut into 1.8×2.5 cm 
rectangles. To obtain the folding endurance of the buccal films, The film 
was repeatedly folded at the same place until it broke or until it folded 
more than 300 times at the same crease without breaking. The number 
of folds before breaking provided a value of folding endurance [8].
Percent moisture absorption (PMA)
An absorption test (using percent moisture) was performed to quantify 
the physical stability of each buccal film type under high humidity 
conditions. To do this, three film pieces were excised and weighed. Then, 
the films were placed in a desiccator containing a saturated solution of 
sodium chloride while maintaining the humidity inside the desiccator 
at 70%. After 3 days the films were removed, weighed and PMA was 
calculated. Average PMA of three films was calculated by dividing (final 
weight - initial weight with initial weight then times 100%.
Percent moisture loss (PML)
PML was determined to evaluate the integrity of each film type under 
dry conditions. Three film pieces were excised and weighed, then placed 
them in a desiccator containing fuzed anhydrous calcium chloride while 
maintaining the humidity inside the desiccator at 2%. After 3 days, the 
film samples were removed and weighed. Average PML was calculated 
by dividing (final weight - initial weight) with initial weight then times 
100%.
Tensile strength and elongation
To understand the mechanical endurance the films,  Tensile strength 
and elongation were analyzed using a texture analyzer (TA.XT2 Rheoner 
3305, Germany) and XTRA Dimension software. The films were placed 
between two nippers and pulled them apart at a speed of 100 mm/min. 
The force needed to fracture the film was determined by measuring 
total weight loaded on the string at the moment of breakage. The weight 
required to break the film was defined as its tensile strength. Tensile 
strength was determined by dividing force when films fractured (N) 
with area of film (mm2). Percentage of elongation was calculated by 
dividing final length - initial length with initial length then times 100%.
Swelling index
The increase in weight due to swelling for each films type was 
measured by placing samples in a thoroughly cleaned Petri dish with 
graph paper placed beneath it. Then, 50 mL phosphate buffer (pH 6.8) 
was poured into the Petri dish. Any increase in the weight of the patch 
was recorded at 15 min intervals over a 60-min period. Percentage of 
swelling (swelling index) was determined by dividing (Xt–X0) with X0 
then times 100, where Xt is the weight of swollen film after time t and 
X0 is the weight of a film at the time.
Ex vivo mucoadhesion time
The time which was needed by each film to detach (ex vivo) from freshly 
excised goat buccal mucosa was evaluated. The goat buccal tissues were 
fixed on a glass side with cyanoacrylate glue. A side of the film (1.8×2.5 
cm) was moistened with 1 mL of phosphate buffer (pH 6.8) and the goat 
buccal tissue was pasted to it by applying a light force (with a fingertip) 
for 20 s. A beaker glass was filled with 200 mL of phosphate buffer (pH 
6.8) and maintained it at 37°C. Buffer solution in the beaker glass was 
stirred at 50 rpm to simulate the environment of a buccal cavity. Film 
adhesion were observed, and the time required for the film to detach 
from the buccal tissue was recorded.
In vitro mucoadhesion
Mucoadhesion strength in vitro was evaluated using a texture analyzer. 
Goat buccal sections to model mucosa was used for these experiments. 
First, goat buccal sections were kept in a phosphate buffer (pH 6.8) 
under refrigeration. A buccal film section was removed from the 
refrigerator and attached to buccal tissue for 50 s. Then, tissue and film 
were attached to a texture analyzer plate. The texture analyzer probe 
was operated at a force of 150 g force (gF) at a speed 0.5 mm/s. The 
probe was then lifted at a speed 1 mm/s. The curve between time and 
force were recorded until the film became detached from the tissue 
surface. This procedure quantified bioadhesive strength in units of gF 
[9].
Drug content
Buccal films of each formulation containing equal amounts of DH were 
dissolved into 250 mL of phosphate buffer (pH 6.8) and then stirred and 
filtered the resulting solution. The amount of DH in each sample was 
determined spectrophotometrically at at λ 236 nm. Average DH amount 
of three films was defined  as drug content. 
In vitro drug release
In vitro drug release from buccal films was conducted using a 
modification of dissolution procedure. The dissolution medium 
consisted of 250 mL of phosphate buffer solution (pH 6.8). The amount 
of drug released was measured at 37±0.5°C with a rotation speed of 
50 rpm. One side of a buccal film was glued to a glass side with an 
instant adhesive (cyanoacrylate adhesive). The film with object glass 
Table 1: Formulation of diltiazem HCl mucoadhesive buccal films
Ingredients Formula
F1 F2 F3 F4
PCSPh (pregelatinized cassava starch phthalate (PCS)) 4.5 6 - 6
PCS - - 6 -
DH 2.491 2.491 2.491 2.491
Propylene glycol 1.125 1.125 1.125 1.125
Glycerol 0.9 0.9 0.9 0.9
Aspartame 0.2 0.2 0.2 0.2
Aquadest 90.784 89.284 89.284 88.609
DH: Diltiazem hydrochloride
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was placed at the dissolution vessel so that the film form faced upright, 
thereby allowing the drug to be released only from the upper side of 
the film. Samples of 5 mL were withdrawn at pre-determined time 
intervals and replaced with fresh medium. Samples were analyzed after 
appropriate dilution by UV spectrophotometry (Shimadzu, Japan) at 
λ 236 nm. The drug release experiments were conducted in triplicates, 
and the mean values were plotted against time.
RESULTS AND DISCUSSION
In this study, the buccal films of diltiazem HCl were prepared using a 
solvent casting method. First, various amounts and types of polymers 
were mixed gradually in aquadest with a magnetic stirrer. The polymers 
provided a physical and chemical contact with the buccal tissue. The 
obtained four types of diltiazem HCl buccal films were characterized 
in terms of weight, thickness, surface pH, percent moisture absorption, 
percent moisture loss, swelling index, folding endurance, drug 
content, in vitro drug release, mucoadhesion strength, mucoadhesion 
time, tensile strength, and elongation potential. Results of these 
characterizations are shown in Table 2. The results were white, thin, 
soft, little moist, and odorless. Using a SEM, we could see that all films 
had rough surfaces on the topside, which physically differed among the 
four formulations (Fig. 1). We expect that such rough surfaces (Figs. 1-3) 
should provide useful attachment surfaces on mucosal tissue, which, in 
turn, should allow for a rapid release of a drug (Fig. 4).
There were high correlation between weight and thickness of buccal 
films (Table 2) and amounts of polymer used in the formulations. Our 
result showed the higher concentration of polymer in formula, the 
heavier and thicker the obtained films. Table 2 shows that Formulas 2 
and 4 (containing 6% PCSPh) were heavier and thicker than formula 
1 because they contained the more PCSPh polymer. Formula 3 was 
the heaviest and thickest film, perhaps because the viscosity of PCS is 
higher than the viscosity of PCSPh.
Considering that acidic or alkaline pH may irritate buccal mucosa and 
influence the hydration rate of the polymers, we maintained the films at 
a surface pH similar to that of saliva. Thus, all formulations of diltiazem 
HCl buccal films were prepared at the range of pH 5.6 – 7.0 (Table 2).
The moisture content of films showed that there was no significant 
difference among film types (the range in moisture content was 10–13%). 
Theoretically, films placed in moist conditions will gain weight because 
moisture is absorbed in response to the hygroscopic characteristics 
of the polymer and plasticizer, whereas films placed in dry conditions 
will lose weight in response to the moisture in films being pulled from 
the mucosa to surrounding environment. In our study, we used polyols 
as plasticizers. The tendency of a polyol to absorb water depends on 
its molecular weight and number of its hydroxyl groups. In our films, 
moisture absorption (%PMA) was larger than moisture loss (%PML) 
(Table 3). Absorption was increased because the plasticizer was effective 
in binding with moisture in the environment surrounding the mucosa 
by interacting with starch molecules and so could retain moisture [10]. 
The ability of the films to absorb and lose moisture differed by film type 
(formula) (i.e., PMA: F1 > F2 > F3 > F4; PML: F1 > F3 > F4 > F2).
Tensile strengths and elongation were determined to understand 
the mechanical endurance of the films we tested. Film plasticization 
can decrease the molecular interaction between polymers by 
decreasing fragility and increasing flexibility of the polymers which is 
Table 2: Characteristics of the produced mucoadhesive buccal films
Formula Weight (g) Thickness (mm) Surface pH Water content (%) PMA (%) PML (%)
F1 0.0953±0.0036 0.16±0.01 5.89±0.03 10.58±3.54 182.21±45.50 9.12±1.07
F2 0.1123±0.0109 0.19±0.02 5.87±0.34 12.14±2.43 139.37±5.55 6.47±0.34
F3 0.1554±0.0028 0.27±0.01 6.03±0.05 13.04±1.66 118.03±2.61 8.29±0.88
F4 0.1184±0.0144 0.19±0.02 5.77±0.06 12.85±1.88  57.17±8.42 7.83±0.20
PMA: Percent moisture absorption, PML: Percent moisture loss
Fig. 1: Scanning electron microscope micrograph of the produced 
buccoadhesive films (top side with 2000× magnificancy)
Fig. 2: Scanning electron microscope micrograph of the produced 
buccoadhesive films (bottom side with 2000× magnificancy)
representated by tensile strength and elongation [11]. Films that are 
intended to release a drug through buccal delivery should possess 
sufficient strength to withstand the mechanical stresses imposed 
during production, handling, and application. The folding endurance of 
the films was examined to estimate their abilities to withstand repeated 
bending, folding, and creasing (at the same location), conditions likely to 
be encountered during production and transportation. All the prepared 
films showed sufficient flexibility for easy handling and possessed 
excellent folding endurance of over than 300 folds.
Tensile strength, defined as the maximum stress which still can be 
handled by a material, is an indication of the strength and elasticity 
of a film. We determined that tensile strength increased with polymer 
content. Among the various formulations we tested, film F2 exhibited the 
highest tensile strength (0.84 N/mm2) (Table 2). Effective films made 
from cassava starch derivatives tend to have the low tensile strength and 
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high elongation potential [12]. The various formulations of plasticizers 
we used affected films differently (Table 2). We compared percent 
elongation for film F1 with blank films (those without a plasticizer). 
Films F1 and F4 did not significantly differ in percent elongation. 
Different polymers were used in formulations for films F2 and F3, but 
they did not significantly differ from one another in percent elongation.
Swelling index
Swelling index of films was measured by observing weight gain of 
the film after being placed for 4 h in a phosphate buffer solution 
(pH 6.8). Weight gain represents the amount of water that is absorbed 
(hydrated). Degree of polymer hydration indicates the relative ability 
a mucoadhesive polymer to induce mobility in a polymer chain, which 
then allows the polymer and mucin to interpenetrate [8]. The swelling 
index of a buccal film was an important parameter for quantifying the 
magnitude of mucoadhesion. Polymer swelling increases mechanical 
coiling of polymers by opening the interaction site of the hydrogen bond 
between a polymer and mucosa. We observed that all films retained 
their forms within the first 30 mins of contact. After 30 min, film F3 
started to erode, whereas films F1, F2, and F4 retained their forms, 
but had begun erode a bit in response to a slight loss in weight. After 
45 min, the swelling index of film F3 could not be measured because it 
had deteriorated completely. From our tests, we determined that PCS 
films were more easily eroded than PCSPh films.
Film F2’s swelling index was the highest after 30 min of contact with 
mucosa. This was likely because 6% of PCSPh polymer absorbed more 
water than 4.5% of PCSPh polymer. Although the formulation of films 
F2 and F4 contained the same concentration of polymers, the swelling 
index of film F4 was less, probably because it had a lower concentration 
of plasticizer, which, in turn, caused it dissolve more quickly (this led to 
a smaller weight gain than film F2). For the first 60 min after contact, 
film F4 experienced more swelling than film F1, but after 60 min, film 
F1 experienced more swelling (Table 4). We presumed that after the 
plasticizer had dissolved (after 60 min) after which water diffused to the 
film more rapidly. Swelling index is an important indicator of predicting 
the rate of drug release from mucosal films. The more hydrated and the 
higher swelling index of polymer, the higher drug release rate from the 
film.
Mucoadhesion test
Our mucoadhesion test determined the strength of a film’s adhesion 
on goat mucosa and the length of time it adheres before detaching 
(Table 5). Film F2, with greatest swelling, also showed the strongest 
adhesion to the mucosa. From our analysis of mucoadhesive strength and 
texture, we determined that there was no significant difference among 
film types (formulations) in mucoadhesive strength or length of time 
before detachment. However, our tests of ex vivo mucoadhesion showed 
disparate results for length of adhesion. Among all tested films, length of 
time for ex vivo mucoadhesion was highest (114.7±9.3 min) for film F3. 
This was likely because it contained a higher number of hydroxyl groups 
than the other films, which we formulated with the PCSPh polymer. 
Thus, film F3 may have had more interpenetration of its polymer with 
the mucosal tissue. Films F1 and F4 had the shortest period of ex vivo 
mucoadhesion, perhaps due to effects of their plasticizers (i.e., their 
plasticizers interacted with the polymer chain in a manner that decreased 
mucin concentration). Although film F2 adhered to the mucosa (ex vivo) 
longest, this film type did not adhere longer than film F3.
Fig. 3: Scanning electron microscope micrograph of the produced 
buccoadhesive films (cross-section with 500× magnificancy)
Fig. 4: In vitro dissolution profiles of diltiazem HCl from the 
muccoadhesive buccal films
Table 3: Comparison of tensile strength, elongation ability, ex vivo mucoadhesion time, and drug content of the produced buccoadhesive 
films
Formula Tensile strength (N/mm2) Elongation (%) Ex vivo mucoadhesion time (min) Drug content (mg/film)
1 0.34±0.05 445.87±75.50 2.7±2.7 23.3±2.2
2 0.84±0.02 272.23±60.99 57.1±20.3 24.4±2.3
3 0.49±0.09 333.37±106.16 114.7±9.3 27.2±4.2
4 0.17±0.02 495.50±28.52 4.7±3.8 21.3±3.2
Table 4: Swelling index (% swelling) of the produced buccoadhesive films
Time (min) F1 F2 F3 F4
15 266.39±59.18 335.00±24.19 297.87±29.24 367.01±52.82
30 342.78±68.15 391.38±81.32 341.07±11.84 403.36±34.25
45 370.09±46.47 524.08±61.91 402.51±36.62 413.81±24.64
60 404.03±47.10 546.72±40.37 - 415.66±21.55
120 445.74±38.45 563.74±5.84 - 425.42±30.84
240 489.98±43.84 582.17±16.77 - 400.86±23.18
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Drug release study
Films F1, F2, and F4 produced an acceptable drug release profile (Fig. 4). 
That is, all these films released more than 40% of their drug (diltiazem 
HCl) within 15 min and more than 80% within 45 min. After 120 min 
(when the films had completely dissolved), film F2 had released 100% 
of its drug, higher than any of the other films. This suggests that film 
F2 is the most appropriate formulation for rapid and complete (100%) 
release of drugs.
CONCLUSION
Low substitution degree of PCS with phthalate successfully modify the 
excipient characteristics, and its application in low concentration (4.5-
6%) as film-forming polymer produced muccodhesive buccal film with 
a rapid release profile.
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